chlortetracycline is a lipid of Polyketides (PK) class. Chlortetracycline is associated with abnormalities such as Granulomatous Disease, Chronic, Infection, Ischemia, Cerebral Ischemia and Cerebral Infarction. The involved functions are known as Regulation, Binding (Molecular Function), Agent, Stimulus and Process. Chlortetracycline often locates in Protoplasm, Plasma membrane, Membrane, Cytoplasm and specific granule. The associated genes with chlortetracycline are FPR1 gene, P4HTM gene, Homologous Gene, HIST1H1C gene and Microbiome. The related lipids are Lysophosphatidylcholines, Sterols, dilauroyl lecithin, seminolipid and Total cholesterol. The related experimental models are Mouse Model.
To understand associated biological information of chlortetracycline, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
chlortetracycline is suspected in Ischemia, Cerebral Ischemia, Cerebral Infarction, Granulomatous Disease, Chronic, Infection, Antibiotic resistant infection and other diseases in descending order of the highest number of associated sentences.
Disease | Cross reference | Weighted score | Related literature |
---|
We collected disease MeSH terms mapped to the references associated with chlortetracycline
There are no associated biomedical information in the current reference collection.
Associated locations are in red color. Not associated locations are in black.
Location | Cross reference | Weighted score | Related literatures |
---|
Function | Cross reference | Weighted score | Related literatures |
---|
Lipid concept | Cross reference | Weighted score | Related literatures |
---|
Gene | Cross reference | Weighted score | Related literatures |
---|
Mouse Model are used in the study 'Chlortetracycline and demeclocycline inhibit calpains and protect mouse neurons against glutamate toxicity and cerebral ischemia.' (Jiang SX et al., 2005).
Model | Cross reference | Weighted score | Related literatures |
---|
Authors | Title | Published | Journal | PubMed Link |
---|---|---|---|---|
McCULLOCH EC et al. | Aureomycin in the treatment of staphylococcic mastitis in cows. | 1949 | Vet Med | pmid:18121337 |
SPINK WW | Investigations with the antibiotic aureomycin. | 1949 | Minn Med | pmid:18122411 |
TEMPESTINI O | [Preliminary results of the use of aureomycin in oral and perioral infections]. | 1949 | Riv Ital Stomatol | pmid:15403951 |
PERRY FG and MARTINEAU PC | Eczema vaccinatum; rapid recovery following treatment with aureomycin. | 1949 | J Am Med Assoc | pmid:15390646 |
LEVADITI C et al. | [Not Available]. | 1949 | Sem Hop | pmid:18135278 |
GOCKE TM et al. | Aureomycin treatment of pneumococcic pneumonia; clinical and laboratory studies on 33 patients. | 1949 | Arch Intern Med (Chic) | pmid:15397490 |
CASE RB | Aureomycin in the treatment of herpes zoster. | 1949 | Calif Med | pmid:18229036 |
DOWLING HF and LEPPER MH | The concentration of aureomycin in urine and cerebrospinal, pleural and ascitic fluids after oral and intravenous administration. | 1949 | J. Clin. Invest. | pmid:18138333 |
BRAINERD H and LENNETTE EH | The clinical evaluation of aureomycin. | 1949 | J. Clin. Invest. | pmid:18147796 |
CRUICKSHANK JC | Failure of aureomycin in experimental melioidosis. | 1949 | Br Med J | pmid:18147831 |